Brainsway (BWAY) Shares Outstanding (2018 - 2026)
Brainsway (BWAY) posted quarterly Shares Outstanding (Entity) of $39.2 million for Q4 2025, down 47.95% year-on-year from $75.3 million in Q4 2024, and down 48.18% on a QoQ basis from $75.6 million in Q2 2025.
Brainsway (BWAY) Shares Outstanding (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Shares Outstanding (Entity) for 8 consecutive years, with $39.2 million the latest figure, recorded in Q4 2025.
- Quarterly Shares Outstanding (Entity) fell 47.95% year-over-year to $39.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $39.2 million (down 47.95% YoY) and the FY2025 annual result came in at $39.2 million, down 47.95% from the prior year.
- Shares Outstanding (Entity) retreated to $39.2 million in Q4 2025 per BWAY's latest filing, from $75.6 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for BWAY reached as high as $75.6 million in Q2 2025 and fell as low as $39.2 million in Q4 2025.
- A 5-year average of $65.0 million and a median of $66.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) jumped 47.91% — and 2025, when it sank 47.95%.
- Year by year, Shares Outstanding (Entity) stood at $65.8 million in 2021, then gained by 0.43% to $66.1 million in 2022, then increased by 0.57% to $66.5 million in 2023, then advanced by 13.19% to $75.3 million in 2024, then plunged by 47.95% to $39.2 million in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $39.2 million, $75.6 million, and $75.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 38.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.01 Mn |
| Dec 31, 2025 | 38.01 Mn |
| Sep 30, 2025 | 75.41 Mn |
| Jun 30, 2025 | 75.41 Mn |
| Mar 31, 2025 | 67.94 Mn |
| Dec 31, 2024 | 67.94 Mn |
| Sep 30, 2024 | 66.57 Mn |
| Jun 30, 2024 | 66.57 Mn |
| Mar 31, 2024 | 66.31 Mn |
| Dec 31, 2023 | 66.31 Mn |
| Sep 30, 2023 | 65.96 Mn |
| Jun 30, 2023 | 65.96 Mn |
| Mar 31, 2023 | 65.96 Mn |
| Dec 31, 2022 | 65.96 Mn |
| Sep 30, 2022 | 62.31 Mn |
| Jun 30, 2022 | 62.31 Mn |
| Mar 31, 2022 | 62.31 Mn |
| Dec 31, 2021 | 62.31 Mn |
| Sep 30, 2021 | 44.91 Mn |
| Jun 30, 2021 | 44.91 Mn |